Skip to Content
Merck
All Photos(1)

Documents

95468

Sigma-Aldrich

Poly(L-lactide)

viscosity ~4.0 dL/g, 0.1 % (w/v) in chloroform(25 °C)

Synonym(s):

L-Lactide polymer, PLA, Poly(L-Lactic acid)

Sign Into View Organizational & Contract Pricing


About This Item

Linear Formula:
CH3O(C6H8O4)nH
MDL number:
UNSPSC Code:
12162002
PubChem Substance ID:
NACRES:
NA.23

description

ester terminated

Quality Level

form

solid

mol wt

Mn 103,000
Mw 259,000

degradation timeframe

>3 years

impurities

<0.5% water

viscosity

~4.0 dL/g, 0.1 % (w/v) in chloroform(25 °C)

Mw/Mn

<2.5

Looking for similar products? Visit Product Comparison Guide

Related Categories

Application

medical device

Other Notes

end group: decyl ester

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Articles

Interest in utilizing biodegradable polymers for biomedical applications has grown since the 1960s.

Aliphatic polyesters such as polylactide, poly(lactide-co-glycolide) and polycaprolactone, as well as their copolymers, represent a diverse family of synthetic biodegradable polymers that have been widely explored for medical uses and are commercially available.

Aliphatic polyesters such as polylactide, poly(lactide-co-glycolide) and polycaprolactone, as well as their copolymers, represent a diverse family of synthetic biodegradable polymers that have been widely explored for medical uses and are commercially available.

Immunosuppressive tumor-associated myeloid cells (TAMC) are responsible for glioblastoma (GBM) resistance to immunotherapies and existing standard of care treatments. This mini-review highlights recent progress in implementing nanotechnology in advancing TAMC-targeted therapies for GBM.

See All

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service